U.S. Oncology Information Systems Market (2025 - 2033) Size, Share & Trends Analysis Report By Product & Service (Software, Professional Services), By Application (Medical Oncology, Surgical Oncology, Radiation Oncology), By End Use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Market Definitions
                        1.2.1. Product & Service Segment
                        1.2.2. Application Segment
                        1.2.3. End Use
                    1.3. Information analysis
                        1.3.1. Market formulation & data visualization
                    1.4. Data validation & publishing
                    1.5. Information Procurement
                        1.5.1. Primary Research
                    1.6. Information or Data Analysis
                    1.7. Market Formulation & Validation
                    1.8. Market Model
                    1.9. Total Market: CAGR Calculation
                    1.10. Objectives
                        1.10.1. Objective 1
                        1.10.2. Objective 2
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Insights Landscape
Chapter 3. U.S. Oncology Information Systems Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook.
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                        3.2.2. Market restraint analysis
                        3.2.3. Market opportunity analysis
                        3.2.4. Market challenges analysis
                    3.3. U.S. Oncology Information Systems Market Analysis Tools
                        3.3.1. Industry Analysis – Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
                            3.3.2.4. Environmental Landscape
                            3.3.2.5. Legal Landscape
                            3.3.2.6. Social Landscape
Chapter 4. U.S. Oncology Information Systems Market: Product & Service Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. U.S. Oncology Information Systems Market Product & Service Movement Analysis
                    4.3. U.S. Oncology Information Systems Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
                    4.4. Software
                        4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                        4.4.2. Patient Information Systems
                            4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                        4.4.3. Treatment Planning Systems
                            4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    4.5. Professional Services
                        4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. U.S. Oncology Information Systems Market: Application Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. U.S. Oncology Information Systems Market Application Movement Analysis
                    5.3. U.S. Oncology Information Systems Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
                    5.4. Medical Oncology
                        5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    5.5. Radiation Oncology
                        5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    5.6. Surgical Oncology
                        5.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. U.S. Oncology Information Systems Market: End Use Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. U.S. Oncology Information Systems Market End Use Movement Analysis
                    6.3. U.S. Oncology Information Systems Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
                    6.4. Hospitals & Diagnostic Imaging
                        6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    6.5. Ablation Care Centers and Cancer Care Centers
                        6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    6.6. Government Institutions
                        6.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    6.7. Research Facilities
                        6.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Company/Competition Categorization
                    7.2. Strategy Mapping
                    7.3. Company Market Position Analysis, 2024
                    7.4. Company Profiles/Listing
                        7.4.1. Elekta AB
                            7.4.1.1. Company overview
                            7.4.1.2. Financial performance
                            7.4.1.3. Product benchmarking
                            7.4.1.4. Strategic initiatives
                        7.4.2. Accuray Incorporated
                            7.4.2.1. Company overview
                            7.4.2.2. Financial performance
                            7.4.2.3. Product benchmarking
                            7.4.2.4. Strategic initiatives
                        7.4.3. Varian Medical Systems (Siemens Healthineers)
                            7.4.3.1. Company overview
                            7.4.3.2. Financial performance
                            7.4.3.3. Product benchmarking
                            7.4.3.4. Strategic initiatives
                        7.4.4. RaySearch Laboratories
                            7.4.4.1. Company overview
                            7.4.4.2. Financial performance
                            7.4.4.3. Product benchmarking
                            7.4.4.4. Strategic initiatives
                        7.4.5. Oracle Corporation
                            7.4.5.1. Company overview
                            7.4.5.2. Financial performance
                            7.4.5.3. Product benchmarking
                            7.4.5.4. Strategic initiatives
                        7.4.6. BrainLab
                            7.4.6.1. Company overview
                            7.4.6.2. Financial performance
                            7.4.6.3. Product benchmarking
                            7.4.6.4. Strategic initiatives
                        7.4.7. Philips Healthcare
                            7.4.7.1. Company overview
                            7.4.7.2. Financial performance
                            7.4.7.3. Product benchmarking
                            7.4.7.4. Strategic initiatives
                        7.4.8. Prowess, Inc.
                            7.4.8.1. Company overview
                            7.4.8.2. Financial performance
                            7.4.8.3. Product benchmarking
                            7.4.8.4. Strategic initiatives
                        7.4.9. DOSIsoft S.A.
                            7.4.9.1. Company overview
                            7.4.9.2. Financial performance
                            7.4.9.3. Product benchmarking
                            7.4.9.4. Strategic initiatives
                        7.4.10. ViewRay Inc.
                            7.4.10.1. Company overview
                            7.4.10.2. Financial performance
                            7.4.10.3. Product benchmarking
                            7.4.10.4. Strategic initiatives
                        7.4.11. MIM Software
                            7.4.11.1. Company overview
                            7.4.11.2. Financial performance
                            7.4.11.3. Product benchmarking
                            7.4.11.4. Strategic initiatives
                        7.4.12. Flatiron
                            7.4.12.1. Company overview
                            7.4.12.2. Financial performance
                            7.4.12.3. Product benchmarking
                            7.4.12.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. oncology information systems market, by component, 2021 - 2033 (USD Million)
Table 3 U.S. oncology information systems market, by application, 2021 - 2033 (USD Million)
Table 4 U.S. oncology information systems market, by end use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Market formulation & validation
Fig. 4 U.S. oncology information systems market: Market outlook
Fig. 5 U.S. oncology information systems market: Segment outlook
Fig. 6 U.S. oncology information systems market: Competitive landscape outlook
Fig. 7 Parent market outlook
Fig. 8 U.S. oncology information systems market driver impact
Fig. 9 U.S. oncology information systems market restraint impact
Fig. 10 U.S. oncology information systems market: Product & Service outlook and key takeaways
Fig. 11 U.S. oncology information systems market: Product & Service movement analysis
Fig. 12 Software market estimates and forecasts,2021 - 2033 (USD Million)
Fig. 13 Patient information systems market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 14 Treatment planning systems market estimates and forecasts,2021 - 2033 (USD Million)
Fig. 15 Professional services market estimates and forecasts,2021 - 2033 (USD Million)
Fig. 16 U.S. oncology information systems market: Application outlook and key takeaways
Fig. 17 U.S. oncology information systems market: Application movement analysis
Fig. 18 Medical oncology market estimates and forecasts,2021 - 2033 (USD Million)
Fig. 19 Medical oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 20 Surgical oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 21 U.S. oncology information systems market: End use outlook and key takeaways
Fig. 22 U.S. oncology information systems market: End use movement analysis
Fig. 23 Hospitals & diagnostic imaging centers market estimates and forecasts,2021 - 2033 (USD Million)
Fig. 24 Ablation care centers and cancer care centers market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 25 Government institutions market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 Research facilities market estimates and forecasts, 2021 - 2033 (USD Million)